Cairo University
Cairo, 12411, Egypt
NCT Number: NCT03908606
the aim of this study was to assess serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Cairo, 12411, Egypt
Periodontitis and diabetes are chronic disorders with a two-way correlation as they can both stimulate an inflammatory response with subsequent formation of inflammatory mediators and cytokines. C reactive protein is an inflammatory plasma marker having a role in the systemic reaction to inflammation. thus, our aim in the current study was to evaluate serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy. A total of 60 patients were enrolled in this study. ELISA was used for determination of hs- CRP. Non- surgical periodontal therapy was carried out for all periodontitis patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supra and subgingival scaling and root planing.
Time frame: 3 months
gain in clinical attachment level
Cairo University
Other
Prognostic Value of Serum Hs-CRP in Periodontitis Patients With or Without Type 2 Diabetes Following Non-surgical Periodontal Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00016835
Diabetes Mellitus, Diabetes Mellitus, Type 2
Ann Arbor, Michigan, United States
View Trial DetailsNCT07327086
Diabetes Mellitus, Diabetes Mellitus, Type 2
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT06582056
Diabetes Mellitus, Diabetes Mellitus, Type 2
Iowa City, Iowa, United States
View Trial DetailsNCT01291875
Diabetes Mellitus, Diabetes Mellitus, Type 2
São Paulo, Brazil
View Trial Details